The journal of nutrition, health & aging

, Volume 14, Issue 8, pp 633–639 | Cite as

Costs of dementia in Hungary

  • K. Érsek
  • T. Kovács
  • A. Wimo
  • K. Kárpati
  • V. Brodszky
  • M. Péntek
  • L. Jönsson
  • A. Gustavsson
  • D. McDaid
  • P. A. Kenigsberg
  • H. Valtonen
  • L. Gulácsi
JNHA: Clinical Neurosciences



The main aim of this paper is to give an overview on the quality of life, health care utilisation and costs of dementia in Hungary.


A cross-sectional non-population based study of 88 consecutive dementia patients and their caregivers was conducted in three GP practices and one outpatient setting in 2008. Resource Utilization in Dementia (RUD), Mini Mental State Examination (MMSE) and quality of life (EQ-5D) were surveyed and cost calculations were performed. Costs of patients living at home were estimated by the current bottom-up cost-of-illness calculations, while costs of nursing home patients were considered by official reimbursement to determine the disease burden from a societal viewpoint.


The mean age of the patients was 77.4 years (SD=9.2), 59% of them were female. The mean MMSE score was 16.70 (SD=7.24), and the mean EQ-5D score was 0.40 (SD=0.34). The average annual cost of dementia was 6,432 Euros per patient living at home and 6,086 Euros per patient living in nursing homes. For the whole demented population (based on EuroCoDe data) we estimated total annual costs of 846.8 million Euros; of which 55% are direct costs, 9% indirect costs and 36% informal care cost. Compared to acute myocardial infarction the total disease burden of dementia is 26.3 times greater.


This is the first study investigating resource utilisation, costs, and quality of life of dementia patients in the Central and Eastern European region. Compared to the general population of Hungary EQ-5D values of the demented patients are lower in all age groups. Dementia related costs are much lower in Hungary compared to Western European countries. There is no remarkable difference between the costs of demented patients living at home and in nursing homes, from the societal point of view.

Key words

Cost-of-illness dementia quality of life Hungary 



Alzheimer's disease


European Collaboration on Dementia


European Quality of life 5 Dimensions


Instrumental activity of daily living


Mild cognitive impairment


Physical activity of daily living


Mini-Mental State Examination


Resource Utilization in Dementia


Standard deviations


National Health Insurance Fund Administration


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brodszky V, Balint P, Geher P, Hodinka L, Horvath G, Koo E et al. Disease Burden of Psoriatic Arthritis Compared to Rheumatoid Arthritis, Hungarian Experiment. Rheum Int 2009;30(2):199–205CrossRefGoogle Scholar
  2. 2.
    Minier T, Péntek M, Brodszky V, Ecseki A, Kárpáti K, Polgár A. Cost-of-illness of patients with systemic sclerosis in a tertiary care centre. Rheumatology. Doi: 10.1093/rheumatology/keq165Google Scholar
  3. 3.
    Péntek M, Kobelt G, Czirják L, Szekanecz Z, Poór G, Rojkovich B et al. Costs of rheumatoid arthritis in Hungary. J Rheumatol. 2007 Jun;34(6):1437PubMedGoogle Scholar
  4. 4.
    Gabányi J, Mónok G, Demencia diagnózisú kórházi esetek költségelemzése, OEP, 2003.Google Scholar
  5. 5.
    Falusi Zs, Gabányi J, Gulácsi L, A demencia epidemiológiája és költsége Magyarországon; jelenlegi helyzet és a várható trendek, Egészségügyi Gazdasági Szemle, 2004;43:1:50–58.Google Scholar
  6. 6.
    Kovács T., Bereczki D., Dementia: The Hungarian perspective, Corvinus Health Policy and Health Economics Miniconference November 12, 2009. http:// Downloaded: 12.01.2010
  7. 7.
    Estimated number of people (2006) with dementia. Alzheimer Europe 2009 Downloaded: 29.12.2009
  8. 8.
    Wimo A, Winblad B, Jönsson L. The worldwide societal costs of dementia: Estimates for 2009. Alzheimers Dement. 2010 Mar;6(2):98–103.CrossRefPubMedGoogle Scholar
  9. 9.
    Wimo A, Jönsson L, Gustavsson A. Cost of illness and burden of dementia — The base option. Alzheimer Europe. Downloaded: 29.12.2009
  10. 10.
    Wimo A, Nordberg G. Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument. Arch Gerontol Geriatr. 2007;44(1):71–81.CrossRefPubMedGoogle Scholar
  11. 11.
    Jonsson L, Berr C. Cost of dementia in Europe. Eur J Neurol. 2005 Jun;12Suppl 1:50–53.CrossRefPubMedGoogle Scholar
  12. 12.
    Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol. 2005;12Suppl 1:1–27.CrossRefPubMedGoogle Scholar
  13. 13.
    SBU. Dementia. A systematic review. Stockholm: Staten beredning för medicinsk utvärdering (SBU) (The Swedish Council on Technology Assessment in Health Care) 2008. Report No.: 172E/1-3Google Scholar
  14. 14.
    Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005 Dec 17;366(9503):2112–2117.CrossRefPubMedGoogle Scholar
  15. 15.
    Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 Suppl 5):S4–S9.PubMedGoogle Scholar
  16. 16.
    Hofman A, Rocca WA, Brayne C, Breteler MM, Clarke M, Cooper B, et al. The prevalence of dementia in Europe: a collaborative study of 1980–1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol. 1991 Sep;20(3):736–748.CrossRefPubMedGoogle Scholar
  17. 17.
    Wimo A, Nordberg G, Jansson W, Grafström M. Assessment of informal services to demented people with the RUD instrument. Int J Geriatr Psychiatry. 2000;15(10):969–971.CrossRefPubMedGoogle Scholar
  18. 18.
    Wimo A, Nordberg G. Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument. Arch Gerontol Geriatr. 2007;44(1):71–81.CrossRefPubMedGoogle Scholar
  19. 19.
    Guerrero-Berroa E, Luo X, Schmeidler J, Rapp MA, Dahlman K, Grossman HT, Haroutunian V, Beeri MS. The MMSE orientation for time domain is a strong predictor of subsequent cognitive decline in the elderly. Int J Geriatr Psychiatry. 2009;24(12):1429–1437.CrossRefPubMedGoogle Scholar
  20. 20.
    Hungarian Central Statistical Office online database,
  21. 21.
    NHIFA online database,
  22. 22.
    Hungarian Tax and Financial Control Administration database,
  23. 23.
    National Audit Office Report Nr. 0820. Summary of the Audit of the Utilization of Funds Appropriated for Nursing by Hospitals and Residential Social Institutions of Local Governments (
  24. 24.
    Jonsson L, Lindgren P, Wimo A, Jonsson B, Winblad B. Costs of MMSE-related Cognitive Impairment. Pharmacoeconomics. 1999;16:409–416.CrossRefPubMedGoogle Scholar
  25. 25.
    Szende A, Németh R. Health-related quality of life of the Hungarian population. Orv Hetil. 2003;144:1667–1674.PubMedGoogle Scholar
  26. 26.
    Wimo A, Jönsson L, Gustavsson A. Regional/National cost of illness estimates. Alzheimer Europe: Downloaded: 29.12.2009
  27. 27.
    Gulácsi L, Májer I, Boncz I, Brodszky V, Merkely B, Maurovich Horváth P, Kárpáti K. Hospital costs of acute myocardial infarction in Hungary; 2003–2005. Orv Hetil. 2007;148(27):1259–1266.CrossRefPubMedGoogle Scholar
  28. 28.
    Leél- ssy L, Sz cs I, Kindler M, Schwarz T. Incidence of Alzheimer pathology in the autopsy material of two hospitals (1996–1997) Clin. Neurosci./Ideggyogy Sz. 1998; 51/suppl. 1:34–35Google Scholar
  29. 29.
    Leél- ssy L, Kindler M, Sz cs I, Schwarcz T. Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease. Clin. Neurosci./Ideggyogy Sz. 2006,. 59(5–6):164–177.Google Scholar
  30. 30.
    Kovács GG, Kovári V, Nagy Z. Frequency of different forms of dementia at the Department of Neuropathology of the Hungarian National Institute of Psychiatry and Neurology during a 3-year period. Clin Neurosci/ Ideggyogy. Sz. 2008;61(1–2) p. 24–32.Google Scholar
  31. 31.
    Leel- ssy, L. Incidence of Alzheimer's dementia in homes for the elderly. Arch Gerontol Geriatr. 1995;21(1):21–26.CrossRefGoogle Scholar
  32. 32.
    Tariska P, Knolmayer J, Kiss é, Urbanics K, Mészáros á, Angyalosné Takó E, Mihocsa I, Baranyai Zs. The first Memory Clinic in Hungary: Experiences based on the data of the first five-year period. Clin Neurosci/ Ideggyogy Sz. 1998; 51/suppl 1.: 40–42.Google Scholar
  33. 33.
    Kálmán J, Boda K, Bende Z, Janka Z. Screening for dementia syndromes: the Hungarian experience with the 7-Minute-Test. Orv Hetil. 2003;144(39):1929–1938.PubMedGoogle Scholar
  34. 34.
    Tariska P, Paksy A. Mini-Cog: a simple method for very brief screening of mental decline. Orv Hetil. 2003;144(17):803–809.PubMedGoogle Scholar
  35. 35.
    Vincze G, Almos P, Boda K, Döme P, Bódi N, Szlávik G, Maglóczki E, Pákáski M, Janka Z, Kálmán J. Risk factors of cognitive decline in residential care in Hungary. Int J Geriatr Psychiatry. 2007;22(12):1208–1216.CrossRefPubMedGoogle Scholar
  36. 36.
    Linka E, Kispál Gy, Szabó T, Bartkó Gy. A dementia sz rése és a betegek egyéves követése egy háziorvosi praxisban. Clin Neurosci/ Ideggyogy Sz. 2001. 54(5–6)Google Scholar
  37. 37.
    Leel- ssy L, Józsa I, Sz s I, Kindler M. Sz r vizsgálatok a dementia korai felderítésére (Családorvosi körzetekben és id sek otthonában). Medicus Universalis 2005. (3)Google Scholar
  38. 38.
    Érsek K, Kárpáti K, Kovács T, Csillik G, Gulácsi LÁ, Gulácsi L: Epidemiology of Dementia in Hungary. Clin. Neurosci./Ideggyogy. Sz. — 2010; 63(5–6): 175–182.Google Scholar
  39. 39.
    Pommer E, Woittiez I, Stevens J. Comparing Care. The care of the elderly in ten EU-countries. The Netherlands Institute for Social Research (SCP). Publication number: 2007/32.Google Scholar
  40. 40.
    Health, Ageing and Retirement in Europe. First Results from the Survey of Health, Ageing and Retirement in Europe (SHARE) Mannheim Research Institute for the Economics of Aging (MEA), 2005.Google Scholar

Copyright information

© Serdi and Springer Verlag France 2010

Authors and Affiliations

  • K. Érsek
    • 1
  • T. Kovács
    • 2
  • A. Wimo
    • 3
  • K. Kárpati
    • 1
  • V. Brodszky
    • 1
  • M. Péntek
    • 1
  • L. Jönsson
    • 4
  • A. Gustavsson
    • 4
  • D. McDaid
    • 5
  • P. A. Kenigsberg
    • 6
  • H. Valtonen
    • 7
  • L. Gulácsi
    • 1
  1. 1.Health Economics and Health Technology Assessment Research CentreCorvinus University of BudapestBudapestHungary
  2. 2.Department of NeurologySemmelweis UniversityBudapestHungary
  3. 3.Karolinska InstituteStockholmSweden
  4. 4.European Health EconomicsLondonUK
  5. 5.London School of Economics and Political ScienceLondonUK
  6. 6.Fondation Médéric AlzheimerParisFrance
  7. 7.University of Eastern FinlandKuopioFinland

Personalised recommendations